TradingKey

关于 Artivion Inc 公司

Artivion, Inc. 是一家医疗器械公司，从事制造、加工和分销用于治疗主动脉疾病、心脏瓣膜疾病、主动脉瘤和主动脉夹层患者的心脏和血管外科手术的医疗器械和可植入人体组织。该公司的部门包括医疗器械和保存服务。医疗器械部门包括主动脉支架移植物、手术密封剂和 On-X 的销售。保存服务部门包括保存心脏和血管可植入人体组织的服务。该公司有四个产品系列：主动脉支架移植物、手术密封剂、On-X 机械心脏瓣膜和相关手术产品以及可植入心脏和血管人体组织。主动脉支架移植物包括主动脉弓支架移植物、腹部支架移植物和合成血管移植物。手术密封剂包括 BioGlue 手术粘合剂产品。该公司还销售或分销 PhotoFix 牛手术贴片。

公司简介

公司代码AORT

公司名称Artivion Inc

上市日期Feb 12, 1993

CEOMr. James Patrick (Pat) Mackin

员工数量1600

证券类型Ordinary Share

年结日Feb 12

公司地址1655 Roberts Boulevard N W

城市KENNESAW

上市交易所NYSE Consolidated

国家United States of America

邮编30144

电话17704193355

网址https://artivion.com/

公司代码AORT

上市日期Feb 12, 1993

CEOMr. James Patrick (Pat) Mackin

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. John E. Davis

Senior Vice President - Global Sales and Marketing

188.49K

+7.55%

Mr. Daniel J. Bevevino

Independent Director

150.06K

+4.40%

Mr. Thomas F. Ackerman

Independent Director

149.90K

+4.41%

Ms. Amy D. Horton, CPA

Chief Accounting Officer, Vice President

142.38K

+6.92%

Mr. Jon W. Salveson

Independent Director

129.84K

+5.12%

Mr. Lance A. Berry, CPA

Chief Financial Officer, Executive Vice President - Finance

121.36K

+10.09%

Mr. James W. Bullock

Independent Director

68.65K

+10.15%

Mr. Jeffrey H. (Jeff) Burbank

Lead Independent Director

53.80K

+13.32%

Dr. Marshall S. Stanton, M.D.

Senior Vice President, Clinical Research and Chief Medical Officer

48.71K

-45.78%

Mr. Matthew A. (Matt) Getz

Vice President - Human Resources

34.12K

-21.64%

名称

名称/职务

职务

持股

持股变动

Mr. John E. Davis

Senior Vice President - Global Sales and Marketing

188.49K

+7.55%

Mr. Daniel J. Bevevino

Independent Director

150.06K

+4.40%

Mr. Thomas F. Ackerman

Independent Director

149.90K

+4.41%

Ms. Amy D. Horton, CPA

Chief Accounting Officer, Vice President

142.38K

+6.92%

Mr. Jon W. Salveson

Independent Director

129.84K

+5.12%

Mr. Lance A. Berry, CPA

Chief Financial Officer, Executive Vice President - Finance

121.36K

+10.09%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Aortic stent grafts

36.60M

36.98%

On X

21.57M

21.80%

Surgical sealants

18.11M

18.29%

Other

2.52M

2.54%

暂无数据

业务

地区

业务USD

名称

营收

占比

Aortic stent grafts

36.60M

36.98%

On X

21.57M

21.80%

Surgical sealants

18.11M

18.29%

Other

2.52M

2.54%

股东统计

更新时间: 5月17日周六

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.46%

Macquarie Investment Management

6.80%

Perceptive Advisors LLC

6.54%

Fidelity Management & Research Company LLC

6.51%

The Vanguard Group, Inc.

6.49%

Other

60.19%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.46%

Macquarie Investment Management

6.80%

Perceptive Advisors LLC

6.54%

Fidelity Management & Research Company LLC

6.51%

The Vanguard Group, Inc.

6.49%

Other

60.19%

股东类型

持股股东

占比

Investment Advisor

57.95%

Investment Advisor/Hedge Fund

28.93%

Private Equity

6.54%

Individual Investor

5.25%

Hedge Fund

1.99%

Research Firm

1.20%

Pension Fund

1.06%

Bank and Trust

0.43%

Sovereign Wealth Fund

0.05%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

390

44.18M

103.45%

+2.14M

2025Q1

402

44.36M

103.89%

+1.66M

2024Q4

380

41.09M

97.75%

+880.04K

2024Q3

367

38.98M

93.02%

-790.24K

2024Q2

349

38.52M

92.17%

-784.32K

2024Q1

347

38.26M

91.68%

-2.02M

2023Q4

342

37.08M

90.20%

-1.57M

2023Q3

339

37.01M

90.02%

-1.95M

2023Q2

331

37.22M

87.77%

-1.77M

2023Q1

335

37.61M

88.87%

-1.51M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

5.75M

13.46%

-106.89K

-1.83%

Mar 31, 2025

Macquarie Investment Management

2.90M

6.8%

+166.78K

+6.09%

Mar 31, 2025

Perceptive Advisors LLC

2.79M

6.54%

--

Mar 31, 2025

Fidelity Management & Research Company LLC

2.78M

6.51%

+1.72M

+161.42%

Mar 31, 2025

The Vanguard Group, Inc.

2.77M

6.49%

-22.88K

-0.82%

Mar 31, 2025

Juniper Investment Company, LLC

2.10M

4.91%

--

Mar 31, 2025

Morgan Stanley Smith Barney LLC

1.94M

4.54%

-50.93K

-2.56%

Mar 31, 2025

Wellington Management Company, LLP

1.73M

4.05%

+67.33K

+4.06%

Mar 31, 2025

State Street Global Advisors (US)

1.53M

3.59%

-13.74K

-0.89%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

1.31M

3.07%

-160.12K

-10.87%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

AAM Sawgrass US Small Cap Quality Growth ETF

2.93%

Unusual Whales Subversive Democratic Trading ETF

2.48%

ROBO Global Healthcare Technology & Innovation ETF

1.7%

SPDR S&P Health Care Equipment ETF

1.64%

Invesco Dorsey Wright Healthcare Momentum ETF

1.53%

Invesco S&P SmallCap Health Care ETF

0.85%

Invesco S&P SmallCap 600 Pure Growth ETF

0.5%

First Trust Small Cap Growth AlphaDEX Fund

0.41%

Invesco S&P SmallCap Momentum ETF

0.39%

Invesco Dorsey Wright SmallCap Momentum ETF

0.37%

AAM Sawgrass US Small Cap Quality Growth ETF

占比2.93%

Unusual Whales Subversive Democratic Trading ETF

占比2.48%

ROBO Global Healthcare Technology & Innovation ETF

占比1.7%

SPDR S&P Health Care Equipment ETF

占比1.64%

Invesco Dorsey Wright Healthcare Momentum ETF

占比1.53%

Invesco S&P SmallCap Health Care ETF

占比0.85%

Invesco S&P SmallCap 600 Pure Growth ETF

占比0.5%

First Trust Small Cap Growth AlphaDEX Fund

占比0.41%

Invesco S&P SmallCap Momentum ETF

占比0.39%

Invesco Dorsey Wright SmallCap Momentum ETF

占比0.37%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Artivion Inc

31.300USD

Artivion Inc

31.300

概览

公司

财务